Featured Research

from universities, journals, and other organizations

Comparison of family health history to personal genomic screening: Which method is more effective for risk assessment of breast, colon, and prostate cancer?

Date:
November 5, 2010
Source:
American Society of Human Genetics
Summary:
Family health history information is a useful and accurate tool for assessing an individual's risk of developing various diseases. Family health history charts -- known as pedigrees -- are also an important tool that is often used in genetic evaluation. While specific personal genetic screening tests may be useful in some situations, research on family history data shows that family health history information may be a more useful initial disease risk assessment tool.

Family health history information is a useful and accurate tool for assessing an individual's risk of developing various diseases. Family health history charts -- known as pedigrees -- are also an important tool that is often used in genetic evaluation. While specific personal genetic screening tests may be useful in some situations, research on family history data shows that family health history information may be a more useful initial disease risk assessment tool.

Related Articles


A group of researchers led by Charis Eng, MD, PhD, Chair and Founding Director of the Genomic Medicine Institute (GMI) of the Cleveland Clinic, and Founding Director and Attending Clinical Cancer Geneticist of GMI's Center for Personalized Genetic Healthcare, investigated the concordance and relevance between family health history-based risk assessment (FHRA) and SNP-based risk assessment through a DTC personal genomic screening (PGS) test. The DTC genetic tests for this study were conducted by Navigenics to assess each participant's personal risk of developing three common types of cancer. Dr. Eng and her colleagues then compared FHRA with Navigenics PGS for breast cancer (22 females), prostate cancer (22 males), and colorectal cancer (44 individuals).

The researchers found that although both FHRA and PGS placed an average of 40% in the same risk categories, there was little concordance between the two for breast, prostate, or colon cancer risks. For instance, the use of FRHA methods classified eight individuals as being at high risk for breast cancer, but only one of the eight was classified as high-risk when assessed via PGS. Overall, FHRA assigned 22 individuals to the hereditary risk category (i.e., due to a high risk mutation in a cancer-predisposing gene), but PGS identified only one of these individuals as high-risk. The researchers also assessed nine individuals with hereditary risk for colorectal cancer, five of whom had proven mutations defining inherited colorectal cancer syndromes. None of the nine were classified as high-risk when assessed through PGS risk analysis.

"Our research findings indicate that family health history assessment is currently a better predictor of cancer risk when compared with personal genomic testing methods," said Dr. Eng. "However, the personal genomic screening tests could potentially become more effective and accurate if combined with family health history information and used as a complementary tool for cancer risk assessment."

"Evaluation of family health history still remains to be the gold standard in personal disease risk assessment," said Eng. "Until further research is conducted to prove that personal genomic screening can accurately predict a person's risk, it is imperative that health care practitioners rely on family history as the primary tool that they use to clinically evaluate each patient's personal risk of developing cancer."

Furthermore, Eng points out that, "A personal family health history report can be completed at little to no cost, and this type of information is typically readily accessible and easily gathered by the patient." She concluded by stating her belief that, "In effect, family health history could potentially be considered as a 'secret weapon' in the integration of personalized medicine and genetic knowledge into clinical practice."

This research was presented at the American Society of Human Genetics 60th Annual Meeting, which was held November 2-6, 2010, in Washington, D.C.


Story Source:

The above story is based on materials provided by American Society of Human Genetics. Note: Materials may be edited for content and length.


Cite This Page:

American Society of Human Genetics. "Comparison of family health history to personal genomic screening: Which method is more effective for risk assessment of breast, colon, and prostate cancer?." ScienceDaily. ScienceDaily, 5 November 2010. <www.sciencedaily.com/releases/2010/11/101105124230.htm>.
American Society of Human Genetics. (2010, November 5). Comparison of family health history to personal genomic screening: Which method is more effective for risk assessment of breast, colon, and prostate cancer?. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2010/11/101105124230.htm
American Society of Human Genetics. "Comparison of family health history to personal genomic screening: Which method is more effective for risk assessment of breast, colon, and prostate cancer?." ScienceDaily. www.sciencedaily.com/releases/2010/11/101105124230.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins